BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29125889)

  • 1. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
    Daniel M; Tollefsbol TO
    J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
    Kala R; Shah HN; Martin SL; Tollefsbol TO
    BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
    Meeran SM; Patel SN; Tollefsbol TO
    PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
    Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
    Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
    Lanzilli G; Fuggetta MP; Tricarico M; Cottarelli A; Serafino A; Falchetti R; Ravagnan G; Turriziani M; Adamo R; Franzese O; Bonmassar E
    Int J Oncol; 2006 Mar; 28(3):641-8. PubMed ID: 16465368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aloe emodin inhibits telomerase activity in breast cancer cells: transcriptional and enzymological mechanism.
    Wang S; Yan WW; He M; Wei D; Long ZJ; Tao YM
    Pharmacol Rep; 2020 Oct; 72(5):1383-1396. PubMed ID: 32207090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-proliferative effects of Atractylis lancea (Thunb.) DC. via down-regulation of the c-myc/hTERT/telomerase pathway in Hep-G2 cells.
    Guo WQ; Li LZ; He ZY; Zhang Q; Liu J; Hu CY; Qin FJ; Wang TY
    Asian Pac J Cancer Prev; 2013; 14(11):6363-7. PubMed ID: 24377533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
    Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
    Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells.
    Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
    Cancer Lett; 2009 Dec; 286(2):172-9. PubMed ID: 19560862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.
    Nooshinfar E; Bashash D; Safaroghli-Azar A; Bayati S; Rezaei-Tavirani M; Ghaffari SH; Akbari ME
    Biomed Pharmacother; 2016 Oct; 83():456-465. PubMed ID: 27427852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
    Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
    Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro.
    Moon D; McCormack D; McDonald D; McFadden D
    J Surg Res; 2013 Apr; 180(2):208-15. PubMed ID: 22572619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
    Patel PL; Suram A; Mirani N; Bischof O; Herbig U
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.
    Duangmano S; Dakeng S; Jiratchariyakul W; Suksamrarn A; Smith DR; Patmasiriwat P
    Int J Mol Sci; 2010; 11(12):5323-38. PubMed ID: 21614210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
    Wakimoto R; Ono M; Takeshima M; Higuchi T; Nakano S
    Anticancer Res; 2017 Nov; 37(11):6153-6159. PubMed ID: 29061796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of cytotoxic stilbenes related to resveratrol on the expression of the VEGF, hTERT and c-Myc genes.
    Martí-Centelles R; Falomir E; Murga J; Carda M; Marco JA
    Eur J Med Chem; 2015 Oct; 103():488-96. PubMed ID: 26402726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pterostilbene as a potential novel telomerase inhibitor: molecular docking studies and its in vitro evaluation.
    Tippani R; Prakhya LJ; Porika M; Sirisha K; Abbagani S; Thammidala C
    Curr Pharm Biotechnol; 2014; 14(12):1027-35. PubMed ID: 24433502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.